Sol Gel Technologies Ltd
SLGL4.460USD
+3.730+510.96%
收盤 05/05, 16:00（美東）報價延遲15分鐘
124.24M總市值
虧損本益比TTM
關於 Sol Gel Technologies Ltd 公司
Sol-Gel Technologies Ltd 是一家臨牀階段的皮膚病學公司。該公司專注於識別、開發和商業化用於治療皮膚病的品牌和仿製外用藥物產品。該公司提供一系列產品，包括 twins、sirs-t 和 vered。該公司設計了其專有的基於二氧化硅的微膠囊技術平臺，以提高外用藥物的耐受性和穩定性，同時保持其功效。外用藥物通常難以在實現高功效和高耐受性之間取得平衡。其技術平臺將活性成分包裹在惰性無機二氧化硅殼中，從而在活性成分和皮膚之間形成一道不明顯的屏障。
公司簡介
公司代碼SLGL
公司名稱Sol Gel Technologies Ltd
上市日期Feb 01, 2018
成立日期1997
CEO- -
員工數量34
證券類型Ordinary Share
年結日Feb 01
公司地址Golda Meir 7
城市NESS-ZIONA
上市交易所NASDAQ Capital Market Consolidated
國家Israel
郵編- -
電話97289313433
網址http://www.sol-gel.com
公司代碼SLGL
上市日期Feb 01, 2018
成立日期1997
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
38.13K
+343.42%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Mr. Nissim Bilman
Mr. Nissim Bilman
Vice President - Quality
Vice President - Quality
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
38.13K
+343.42%
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Ms. Yaffa Krindel
Ms. Yaffa Krindel
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
--
--
Mr. Eyal Ben-Or
Mr. Eyal Ben-Or
Chief Financial Officer
Chief Financial Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月4日 週日
更新時間: 5月4日 週日
持股股東
股東類型
持股股東
股東統計
佔比
M.Arkin Dermatology, Ltd.
64.86%
Phoenix Investment and Finances Ltd
8.87%
Migdal Insurance and Financial Holdings Ltd
4.41%
Harel Insurance Investments and Financial Services Ltd
3.30%
Arkin (Moshe)
1.37%
Other
17.19%
持股股東
股東統計
佔比
M.Arkin Dermatology, Ltd.
64.86%
Phoenix Investment and Finances Ltd
8.87%
Migdal Insurance and Financial Holdings Ltd
4.41%
Harel Insurance Investments and Financial Services Ltd
3.30%
Arkin (Moshe)
1.37%
Other
17.19%
股東類型
股東統計
佔比
Corporation
64.86%
Investment Advisor
13.44%
Insurance Company
4.68%
Individual Investor
1.37%
Research Firm
0.60%
Investment Advisor/Hedge Fund
0.05%
Other
15.00%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
35
2.45M
67.44%
+70.65K
2024Q4
35
23.50M
84.37%
-314.30K
2024Q3
34
23.55M
84.52%
-115.49K
2024Q2
31
25.52M
91.61%
+1.51M
2024Q1
30
23.87M
85.67%
+1.61M
2023Q4
31
22.12M
83.66%
-222.95K
2023Q3
30
22.20M
83.99%
-4.35K
2023Q2
29
22.04M
83.43%
-335.52K
2023Q1
32
22.23M
86.47%
+2.20M
2022Q4
34
20.25M
87.57%
+14.11M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
M.Arkin Dermatology, Ltd.
18.07M
64.86%
+2.00M
+12.45%
Apr 03, 2024
Phoenix Investment and Finances Ltd
2.47M
8.87%
--
--
Dec 31, 2024
Migdal Insurance and Financial Holdings Ltd
1.23M
4.41%
--
--
Dec 31, 2024
Harel Insurance Investments and Financial Services Ltd
920.33K
3.3%
--
--
Dec 31, 2024
Arkin (Moshe)
86.00K
0.31%
--
--
Apr 03, 2024
Yelin Lapidot Provident Funds Management Ltd
227.08K
0.82%
-2.10K
-0.92%
Dec 31, 2024
Morgan Stanley & Co. LLC
88.24K
0.32%
+54.88K
+164.51%
Dec 31, 2024
Menora Mivtachim Insurance Ltd.
76.11K
0.27%
--
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
39.50K
0.14%
+1.80K
+4.77%
Dec 31, 2024
查看更多
持股ETF
更新時間: 3 小時前
更新時間: 3 小時前
機構名稱
佔比
Invesco Raymond James SB-1 Equity ETF
0%
Invesco Raymond James SB-1 Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據